Skip to search formSkip to main contentSkip to account menu

certolizumab pegol

Known as: CERTOLIZUMAB, Certolizumab Pegol [Chemical/Ingredient], Pegol, Certolizumab 
A Fab fragment of a recombinant, humanized monoclonal antibody directed against the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha… 
National Institutes of Health

Related topics

Related topics

15 relations
1 ML certolizumab pegol 200 MG/ML Prefilled Syringe1 ML certolizumab pegol 200 MG/ML Prefilled Syringe [Cimzia]In Bloodagonists

Broader (2)

Antirheumatic AgentsImmunosuppressive Agents

Narrower (2)

CDP870Cimzia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Tuberculin test conversion in patients with chronic inflammatory arthritis receiving biological therapy
Objective The blockade of inflammatory mediators produced by biological therapies is associated with an increased risk of… 
Review
2018
Review
2018
Certolizumab Pegol for the Treatment of Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Overview of 3 Randomized Controlled Trials
Abstract not available. Disclosures:  Study sponsored by UCB Pharma. Copyright 2018 SKIN 
Review
2016
Review
2016
Vedolizumab Compared with Certolizumab in the Therapy of Crohn Disease: A Systematic Review and Indirect Comparison
The increasing prevalence of Crohn disease (CD) underscores the need to identify new effective drugs, which is particularly… 
2014
2014
Modern treatment of rheumatoid arthritis in cows.
  • K. Ma
  • 2014
  • Corpus ID: 2667808
Rheumatoid arthritis (RA) is a chronic autoimmune disease, which is thought to be one of the major public health problems in the… 
2011
2011
Glosa do uchwały uchwały składu siedmiu Sędziów Sądu Najwyższego z dnia 28 stycznia 2010 roku (III CZP 91/09, OSNC 2010/6/85)
2010
2010
Psoriatic skin lesions induced by certolizumab pegol.
dysesthesia but showed no skin eruption. Neuropathic pain might lead to sympathetic hyperactivity or decreased muscular activity… 
2010
2010
A Case Report of Nephrotic Syndrome Due to Intake of Certolizumab Pegol in a Patient With Crohn's Disease
A Case Report of Nephrotic Syndrome Due to Intake of Certolizumab Pegol in a Patient With Crohn's Disease 
2005
2005
Effect of the Anti-TNF Agents, Adalimumab, Etanercept, Infliximab, and Certolizumab PEGOL (CDP870) on the Induction of Apoptosis in Activated Peripheral Blood Lymphocytes and Monocytes: 806
2002
2002
Uchwała Sądu Najwyższego z dnia30 maja 2001 r. [III CZP 19/01] : [dot. błędów w wypełnianiu urzędowych formularzy obowiązujących w sprawach cywilnych] : glosa
1999
1999
Determination of the site of incorporation of cobalt in CoZnPO-CZP by multiple-wavelength anomalous-dispersion crystallography.
Data were collected from a crystal of CoZnPO-CZP {sodium cobalt-zinc phosphate hydrate, Na(6)[Co(0.2)Zn(0.8)PO(4)](6).6H(2)O… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)